← back to search

Sharlene M. Day

University of Pennsylvania · US
Area of research
Cardiology and Cardiovascular Medicine · protein folding alphafold
Research interest
Research interests include Cardiomyopathy and Myosin Studies, Cardiovascular Effects of Exercise, Cardiovascular Function and Risk Factors, and Cardiac electrophysiology and arrhythmias.
h-index
57
citations
12,684
works
262
NIH funding
primary concept
Medicine
email

Recent publications

Deep-learning analysis of 3D microarchitectural remodeling in hypertrophic cardiomyopathy.
2026cited by 0position: contributordoi
Differences in Disease Trajectory, Comorbidities, and Mortality in Sarcomeric and Nonsarcomeric Hypertrophic Cardiomyopathy.
2026cited by 0position: contributordoi
The Natural History of Massive Left Ventricular Hypertrophy in Pediatric Hypertrophic Cardiomyopathy: A Multiregistry Analysis.
2026cited by 0position: contributordoi
Advances in the study and treatment of genetic cardiomyopathies
Cell 2025cited by 26position: middledoi
Common-variant and rare-variant genetic architecture of heart failure across the allele-frequency spectrum
Nature Genetics 2025cited by 23position: middledoi
Low Penetrance Sarcomere Variants Contribute to Additive Risk in Hypertrophic Cardiomyopathy.
2025cited by 11position: contributordoi
Proteomic Analysis of Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Clinical Trial
Circulation Heart Failure 2025cited by 3position: middledoi
Proteomic Analysis of Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Clinical Trial.
2025cited by 3position: contributordoi
Sex-Specific Clinical and Genetic Factors Associated With Adverse Outcomes in Hypertrophic Cardiomyopathy.
2025cited by 3position: contributordoi
The contribution of <i>RBM20</i> truncating variants to human cardiomyopathy
2025cited by 3position: contributordoi
Polygenic Background and Penetrance of Pathogenic Variants in Hypertrophic and Dilated Cardiomyopathies
2025cited by 1position: contributordoi
Response by Maurizi et al to Letter Regarding Article, "Long-Term Outcomes After Septal Reduction Therapies in Obstructive Hypertrophic Cardiomyopathy: Insights From the SHARE Registry".
2025cited by 0position: contributordoi
Investigating the role of long non-coding RNA in hypertrophic cardiomyopathy
2025cited by 0position: contributordoi
Long-Term Outcomes After Septal Reduction Therapies in Obstructive Hypertrophic Cardiomyopathy: Insights From the SHARE Registry
Circulation 2024cited by 44position: middledoi
Long-Term Outcomes After Septal Reduction Therapies in Obstructive Hypertrophic Cardiomyopathy: Insights From the SHARE Registry.
2024cited by 34position: contributordoi
Vigorous Exercise in Patients With Congenital Long QT Syndrome: Results of the Prospective, Observational, Multinational LIVE-LQTS Study
Circulation 2024cited by 19position: middledoi
Sports Participation by Athletes With Cardiovascular Disease
Journal of the American College of Cardiology 2024cited by 15position: middledoi
Vigorous Exercise in Patients With Congenital Long QT Syndrome: Results of the Prospective, Observational, Multinational LIVE-LQTS Study.
2024cited by 13position: contributordoi
Quality of Life and Exercise Capacity in Early Stage and Subclinical Hypertrophic Cardiomyopathy: A Secondary Analysis of the VANISH Trial
Circulation Heart Failure 2024cited by 6position: middledoi
Quality of Life and Exercise Capacity in Early Stage and Subclinical Hypertrophic Cardiomyopathy: A Secondary Analysis of the VANISH Trial.
2024cited by 4position: contributordoi
High-intensity exercise training using a rotarod instrument (RotaHIIT) significantly improves exercise capacity in mice.
2024cited by 3position: contributordoi
A rare splice-site variant in cardiac troponin-T ( <i>TNNT2)</i> : The need for ancestral diversity in genomic reference datasets
2024cited by 3position: contributordoi
Centennial Collection: Hypertrophic Cardiomyopathy.
2024cited by 2position: contributordoi
Sex-Specific Effects of &lt;i&gt;MTSS1&lt;/i&gt; Downregulation on Dilated Cardiomyopathy.
2024cited by 2position: contributordoi
Vigorous Exercise in Patients With Hypertrophic Cardiomyopathy
JAMA Cardiology 2023cited by 123position: middledoi
Rationale and Design of the ORCCA (Outcomes Registry for Cardiac Conditions in Athletes) Study
Journal of the American Heart Association 2023cited by 27position: middledoi
Cardiac Remodeling in Subclinical Hypertrophic Cardiomyopathy
JAMA Cardiology 2023cited by 22position: middledoi
Rationale and Design of the ORCCA (Outcomes Registry for Cardiac Conditions in Athletes) Study.
2023cited by 14position: contributordoi
Left Ventricular Systolic Dysfunction in Patients Diagnosed With Hypertrophic Cardiomyopathy During Childhood: Insights From the SHaRe Registry.
2023cited by 12position: contributordoi
Novel Insights Into DMD-Associated Dilated Cardiomyopathy.
2023cited by 3position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 26 papers (2020–2026)Carolyn Y. Ho · Brigham and Women's Hospital13 papers (2014–2025)Mark W. Russell · Cleveland Clinic11 papers (2013–2024)Jodie Ingles · Johns Hopkins Medicine10 papers (2017–2026)Euan A. Ashley · Stanford Health Care8 papers (2013–2021)Iacopo Olivotto · Baim Institute for Clinical Research7 papers (2020–2026)Steven D. Colan · University of Utah7 papers (2016–2019)Iacopo Olivotto · Harvard University7 papers (2014–2025)Joseph W. Rossano · Azienda Ospedaliero-Universitaria Careggi7 papers (2019–2026)Neal K. Lakdawala · Harvard University7 papers (2017–2025) · 6 papers (2020–2026)Carolyn Y. Ho · Lung Institute6 papers (2020–2026)Christine E. Seidman · Harvard University6 papers (2017–2026)Alexandre C. Pereira · Brigham and Women's Hospital6 papers (2018–2024)Michelle Michels · Thorax Foundation5 papers (2020–2026)Christopher Semsarian · Azienda Ospedaliero-Universitaria Careggi5 papers (2020–2024)Neal K. Lakdawala · Azienda Ospedaliero-Universitaria Careggi5 papers (2020–2026)James S. Ware · University of Amsterdam5 papers (2020–2026)Charles E. Canter · St. Louis Children's Hospital5 papers (2016–2024)Christopher Semsarian · Centenary Institute5 papers (2013–2021)